The low activity of lysosomal acid lipase (LAL) could be involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is a common feature in morbidly obese patients. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatotic liver disease.